Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Zenith share issue

tada

Nov 13, 2017 11:10PM

Re: Zenith share issue

BearDownAZ

Nov 14, 2017 12:34PM

Re: Zenith share issue

BearDownAZ

Nov 14, 2017 12:47PM

Re: Zenith share issue

Nextblockbuster

Nov 14, 2017 01:11PM

Re: Zenith share issue

jbuffett62

Nov 15, 2017 11:07AM

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith share issue

posted on Nov 15, 2017 12:39PM

In the Zenith last webcast last month in October DM specifically stated we will be issuing $10 mil very shortly, not sure if that was $10 mil USd or Canadian, If he didn't know it was 100% happening , I doubt he would have stated that way or he would have stated we may issue $10 mil

My question is whether it will be priced out at the enterprise value they stated in the pressy, which was $350 mil USd which i beleive works out to $3 USD per share if i am correct, I ahve my doubts and would love to be surprised